Oe pparγ

Manufactured by GenePharma

Oe-PPARγ is a lab equipment product from GenePharma. It is a tool used for the analysis of PPARγ (Peroxisome Proliferator-Activated Receptor Gamma) expression and activity. The core function of Oe-PPARγ is to facilitate the study of this important nuclear receptor, which plays a crucial role in various biological processes.

Automatically generated - may contain errors

Lab products found in correlation

Sh snhg1, by GenePharma (2 mentions) Sh mdm2, by GenePharma (2 mentions) Oe snhg1, by GenePharma (2 mentions) Mir 9 3p inhibitor, by GenePharma (2 mentions) Oe mdm2, by GenePharma (2 mentions) Lipofectamine 3000, by Thermo Fisher Scientific (2 mentions) Inhibitor nc, by GenePharma (2 mentions) Oe nc, by GenePharma (2 mentions) Scramble shrna, by GenePharma (1 mentions)

2 protocols using oe pparγ

Lentiviral Knockdown and Overexpression

Check if the same lab product or an alternative is used in the 5 most similar protocols

Lentiviruses expressing specific targeted knockdown SNHG1 [short hairpin-SNHG1 (sh-SNHG1)] and MDM2 (sh-MDM2) sequences and a scramble shRNA (sh-NC; control shRNA) were constructed by GenePharma (Shanghai, China) (Table 2). Lentiviruses overexpressing SNHG1 (oe-SNHG1), MDM2 (oe-MDM2), and PPARγ (oe-PPARγ), oe-NC, Inhibitor NC, and miR-9-3p inhibitor were obtained from GenePharma. Transfection was implemented using Lipofectamine 3000 (Invitrogen, Carlsbad, CA, USA).

Cai H., Xu H., Lu H., Xu W., Liu H., Wang X., Zhou G, & Yang X. (2022). LncRNA SNHG1 Facilitates Tumor Proliferation and Represses Apoptosis by Regulating PPARγ Ubiquitination in Bladder Cancer. Cancers, 14(19), 4740.

+ Open protocol

+ Expand

Lentiviral Knockdown and Overexpression

Check if the same lab product or an alternative is used in the 5 most similar protocols

Lentiviruses expressing speci c targeted knockdown SNHG1 [short hairpin-SNHG1 (sh-SNHG1)] and MDM2 (sh-MDM2) sequences and a scramble shRNA (sh-NC; control shRNA) were constructed by GenePharma (Shanghai, China) (Table 2). Lentiviruses overexpressing SNHG1 (oe-SNHG1), MDM2 (oe-MDM2), and PPARγ (oe-PPARγ), oe-NC, Inhibitor NC, and miR-9-3p inhibitor were obtained from GenePharma. Transfection was implemented using Lipofectamine 3000 (Invitrogen, Carlsbad, CA, USA).

Xu W., Hu Y., Xu H., Liu H., Wang X., Zou Q., Yang X., & Cai H. (2021). The Oncogenic Capacities of Long Noncoding RNA SNHG1 in Bladder Cancer by inducing proliferation and repressing apoptosis via upregulation of microRNA-9-3p-targeted MDM2.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!